Related references
Note: Only part of the references are listed.Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
Rebecca L. Charlton et al.
PARASITOLOGY (2018)
Synthesis of polymeric bismuth chlorido hydroxamato complexes; X-ray crystal structure and antibacterial activity of a novel Bi(III) salicylhydroxamato complex
Donal M. Keogan et al.
INORGANICA CHIMICA ACTA (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives
Gebremedhin S. Hailu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The enemy within: Targeting host-parasite interaction for antileishmanial drug discovery
Suzanne Lamotte et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Leishmaniasis drug discovery: recent progress and challenges in assay development
Bilal Zulfigar et al.
DRUG DISCOVERY TODAY (2017)
Glycosylated metal chelators as anti-parasitic agents with tunable selectivity
Andrew Reddy et al.
DALTON TRANSACTIONS (2017)
Novel class of Bi(III) hydroxamato complexes: synthesis, urease inhibitory activity and activity against H-pylori
D. M. Keogan et al.
DALTON TRANSACTIONS (2016)
Stability and toxicity of tris-tolyl bismuth(V) dicarboxylates and their biological activity towards Leishmania major
Yih Ching Ong et al.
DALTON TRANSACTIONS (2015)
Arsenic, antimony, and Leishmania: has arsenic contamination of drinking water in India led to treatment- resistant kala-azar?
Meghan Perry et al.
LANCET (2015)
SHELXT - Integrated space-group and crystal-structure determination
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2015)
Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
Isabel M. Vincent et al.
PROTEOMES (2015)
Bismuth(III) benzohydroxamates: powerful anti-bacterial activity against Helicobacter pylori and hydrolysis to a unique Bi-34 oxido-cluster [Bi34O22(BHA)(22)(H-BHA)(14)(DMSO)(6)]
Amita Pathak et al.
CHEMICAL COMMUNICATIONS (2014)
The role of modern drug discovery in the fight against neglected and tropical diseases
Jeremy N. Burrows et al.
MEDCHEMCOMM (2014)
Anti-leishmanial activity of heteroleptic organometallic Sb(V) compounds
Muhammad Irshad Ali et al.
DALTON TRANSACTIONS (2013)
A novel platinum complex of the histone deacetylase inhibitor belinostat: Rational design, development and in vitro cytotoxicity
James P. Parker et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
The prevalence of metal-based drugs as therapeutic or diagnostic agents: beyond platinum
Declan Gaynor et al.
DALTON TRANSACTIONS (2012)
Synthesis and solution behaviour of stable mono-, di- and trinuclear Pd(II) complexes of 2,5-pyridinedihydroxamic acid: X-ray crystal structure of a novel Pd(II) hydroxamato complex
Darren M. Griffith et al.
INORGANICA CHIMICA ACTA (2012)
Endoplasmic Reticulum Stress-induced Apoptosis in Leishmania through Ca2+-dependent and Caspase-independent Mechanism
Subhankar Dolai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Suberoylanilide hydroxamic acid, a potent histone deacetylase inhibitor; its X-ray crystal structure and solid state and solution studies of its Zn(II), Ni(II), Cu(II) and Fe(III) complexes
Darren M. Griffith et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2011)
Mitochondria and Trypanosomatids: Targets and Drugs
Lianet Monzote Fidalgo et al.
PHARMACEUTICAL RESEARCH (2011)
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group
Vishal Patil et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity
Darren Griffith et al.
CHEMICAL COMMUNICATIONS (2009)
OLEX2: a complete structure solution, refinement and analysis program
Oleg V. Dolomanov et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2009)
Traversing the coordination chemistry and chemical biology of hydroxamic acids
Rachel Codd
COORDINATION CHEMISTRY REVIEWS (2008)
Monohydroxamic acids and bridging dihydroxamic acids as chelators to ruthenium(III) and as nitric oxide donors: syntheses, speciation studies and nitric oxide releasing investigation
Darren Griffith et al.
DALTON TRANSACTIONS (2008)
A short history of SHELX
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2008)
Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase
B Vergnes et al.
ACTA TROPICA (2005)
Drug Insight: histone deacetylase inhibitors - development of the new targeted anticancer agent suberoylanilide hydroxamic acid
WK Kelly et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Synthesis, crystal structures and in vitro antitumor activities of some organoantimony arylhydroxamates
GC Wang et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2005)
Novel platinum(II) ammine hydroxamate and hydroximate complexes and the platinum-assisted hydrolysis of hydroxamic acids
D Griffith et al.
DALTON TRANSACTIONS (2005)
Hydroxamic acids - An intriguing family of enzyme inhibitors and biomedical ligands
CJ Marmion et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2004)
Synthesis and structure of a heptanuclear nickel(II) complex uniquely exhibiting four distinct binding modes, two of which are novel, for a hydroxamate ligand
D Gaynor et al.
CHEMICAL COMMUNICATIONS (2002)
Share Paper
